health-and-medicine8.49 min read
Tiny silica nanoparticles spark tumor death and boost immunotherapy in mouse prostate cancer
1 day ago•Source: ScienceDaily
Health And Medicine News
The latest health and medicine stories, summarized by AI
Featured Health And Medicine Stories
View original source
6.775 min•5 days ago
Karyoptosis: a nuclear-collapse death pathway linked to Alzheimer's and dementia
Scientists have identified karyoptosis as a key mechanism by which brain cells die in Alzheimer's disease and frontotemporal dementia. The process involves nuclear shrinkage and breakdown triggered by toxic protein buildup; blocking the p38 MAP kinase-LaminB1 interaction in neuron cultures reduced markers of this death pathway, offering a potential new target to slow neuron loss and progression of dementia.
More Top Stories
2
Tiny brain vessels drive a common stroke, reshaping prevention
ScienceDaily•7 days ago
3
Aging Muscle Stem Cells: Speedy Repair Comes at a Survival Cost
ScienceDaily•7 days ago
More Health And Medicine Stories
Pre-Waitlist Barriers Block Half of Kidney Transplant Candidates
A nationwide NYU Langone Health study found that 48% of people referred for kidney transplantation never start the required evaluation, and only 19% reach the waitlist. Factors such as being unmarried, obesity, living in rural areas, older age, language barriers (Spanish speakers), and lower income, along with the transplant center and region, significantly influence progression, highlighting large barriers before waitlisting.
PCAIs push pancreatic cancer cells to self-destruct by overactivating key signaling pathways
Researchers found experimental PCAIs kill pancreatic cancer cells and block their spread by hyperactivating MAPK and PI3K/AKT pathways, triggering ROS buildup and apoptosis; the leading compound NSL-YHJ-2-27 cut migration by over 90% at 1 µM and disrupted tumor spheroids, suggesting potential against several KRAS mutations, though further research is needed.
New Cholesterol-Lowering Pathway Uncovered, Points to CTSA-Targeted Therapy
Researchers identify a new pathway where high dietary cholesterol activates the Ral protein, reducing liver LDL receptors and hindering clearance of LDL cholesterol. Blocking the enzyme cathepsin A (CTSA) with a small-molecule inhibitor stabilized LDL receptors and dramatically lowered blood cholesterol in mouse models, suggesting a novel, statin-independent approach and a potential CTSA-targeted treatment that could move to clinical trials, leveraging an existing CTSA inhibitor with prior human safety data.
Arc protein may ferry toxic Tau between neurons, unveiling a new Alzheimer’s therapeutic target
Mouse studies show Arc enables toxic Tau to spread between neurons via extracellular vesicles; removing Arc dramatically reduces Tau transfer, but Arc also helps neurons expel Tau, suggesting therapies should target the Tau-containing vesicles rather than Tau itself—offering a potential new route to slow Alzheimer's progression, though human relevance remains to be proven.
Engineered immune progenitors offer endless supply of cancer-fighting cells
USC researchers developed a stem-cell–inspired method to expand granulocyte-monocyte progenitors (GMPs), enabling long-term self-renewal and genetic engineering to produce macrophages that can target cancer. Engineered GMPs carrying a CAR and an additional immune-activating signal demonstrated tumor-fighting activity and sustained production of immune cells in mice, suggesting a scalable, off-the-shelf cellular immunotherapy with potential applications beyond cancer.
Omega-3 Fish Oil Boosts Brain DHA But Fails to Improve Memory in Alzheimer's Risk Trial
A two-year, double-blind trial found that high-dose DHA from fish oil reached the brain but did not improve memory or cognitive function nor slow hippocampal shrinkage in older adults at risk for Alzheimer's, suggesting supplements may not protect brain health and highlighting the importance of overall diet and lifestyle.
High-Intensity Interval Training Preserves Muscle as Seniors Lose Fat
A six-month study of more than 120 adults in their 70s found that HIIT performed three times weekly reduced body fat while preserving lean muscle, whereas moderate- and low-intensity workouts also cut fat but slightly reduced muscle, suggesting HIIT may offer a stronger path to healthy aging.
Vitamin B12–Derived Therapy Penetrates Brain Barrier to Target Glioblastoma
Researchers report that a vitamin B12–based compound, nitrosylcobalamin (NO-Cbl), can cross the blood-brain barrier, selectively accumulate in glioblastoma tumors, and deliver nitric oxide to cancer cells in preclinical models; it also shows synergistic activity with temozolomide (and TRAIL) to enhance tumor suppression, offering a promising but early approach that requires further validation before clinical use.
Sunlight Alone Fails to Restore Vitamin D in England's High-Risk Groups
Newcastle University researchers analyzed about 300 people across northern Britain and found vitamin D insufficiency remains common year-round, with summer sun not significantly boosting levels in older adults or those from minoritized ethnic backgrounds, prompting calls for year-round strategies and targeted public health measures.
High-Dose Niacin Shows Promise Against Aggressive Brain Cancer
University of Calgary researchers are testing high-dose vitamin B3 (niacin) alongside standard glioblastoma treatment to revive immune cells and attack tumors. In an early Phase I/II trial, 24 patients showed a six-month progression-free survival of 82% — about 28% better than earlier studies — suggesting niacin could boost immune response against this deadly brain cancer, though safety at high doses remains a key consideration as the study continues toward 48 participants by late 2026/early 2027.